Third quarter 2024 results
Third quarter 2024 results were reviewed by management during a conference call with the financial community on Friday October 25, 2024. The presentation was followed by a Q&A session.
Press releases
December 19, 2024
Press Release: Jean-Paul Kress to join Sanofi's Board of Directors
December 17, 2024
Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease
Contact Our Media Team
You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.
Publications
Half Year 2024 Financial Report XBRL Package
Half Year 2024 Financial Report
Declaration of extra-financial performance 2023 (ESG Report)
Half Year 2023 Financial Report